We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EQS.PA

Price
37.40
Stock movement up
+0.55 (1.49%)
Company name
Equasens S. A.
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Health Information Services
Market cap
562.17M
Ent value
719.26M
Price/Sales
2.61
Price/Book
2.54
Div yield
-
Div growth
-
Growth years
-
FCF payout
52.60%
Trailing P/E
13.31
Forward P/E
12.00
PEG
-
EPS growth
12.78%
1 year return
-35.63%
3 year return
-22.13%
5 year return
-10.02%
10 year return
5.74%
Last updated: 2025-04-15

DIVIDENDS

EQS.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E13.31
Price to OCF11.44
Price to FCF15.74
Price to EBITDA6.87
EV to EBITDA8.79

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.61
Price to Book2.54
EV to Sales3.34

FINANCIALS

Per share

Loading...
Per share data
Current share count15.03M
EPS (TTM)2.78
FCF per share (TTM)2.35

Income statement

Loading...
Income statement data
Revenue (TTM)215.16M
Gross profit (TTM)63.78M
Operating income (TTM)48.13M
Net income (TTM)42.25M
EPS (TTM)2.78
EPS (1y forward)3.12

Margins

Loading...
Margins data
Gross margin (TTM)29.64%
Operating margin (TTM)22.37%
Profit margin (TTM)19.64%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash26.21M
Net receivables44.43M
Total current assets137.44M
Goodwill100.76M
Intangible assets43.88M
Property, plant and equipment0.00
Total assets404.34M
Accounts payable18.45M
Short/Current long term debt53.00M
Total current liabilities126.03M
Total liabilities183.30M
Shareholder's equity221.04M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)49.13M
Capital expenditures (TTM)18.85M
Free cash flow (TTM)35.72M
Dividends paid (TTM)18.79M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity19.11%
Return on Assets10.45%
Return on Invested Capital17.59%
Cash Return on Invested Capital14.87%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open37.30
Daily high37.70
Daily low36.95
Daily Volume12K
All-time high122.60
1y analyst estimate62.00
Beta0.91
EPS (TTM)2.78
Dividend per share-
Ex-div date2 Jul 2024
Next earnings date27 Jun 2025

Downside potential

Loading...
Downside potential data
EQS.PAS&P500
Current price drop from All-time high-69.49%-12.04%
Highest price drop-73.37%-56.47%
Date of highest drop31 Mar 20259 Mar 2009
Avg drop from high-17.33%-11.07%
Avg time to new high26 days12 days
Max time to new high1410 days1805 days
COMPANY DETAILS
EQS.PA (Equasens S. A.) company logo
Marketcap
562.17M
Marketcap category
Small-cap
Description
Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id. MOBILITY, a back-office management software; pandaLAB Pro, an instant messaging solution; Id. VENTE, an HAS-certified drug database; Id. COMMANDE, an order management module; dispensing robots; Services Ségur id; id. DOSAGE, a dosage management and printing module; multimeds reconditioning robot; compliance monitoring module; home delivery module; home equipment rental management module; Visiodroits module; and Website connector. The company also provides id. DESK, an informative and interactive dashboard; id. UP!, a real-time monitoring and control application of id management software; id. EASYQ, a queue management solution; Miaterapia; Id. SHOW, an application for managing real-time communications on pharmacy screens; Pharmaweb; TsGatePro; LMO, a dispensary business software; and LGO, a dispensary management software. In addition, it offers DOMILINK HAD software; mobiSOINS mobility tool; MEMORialis, support software for alzheimer's monitoring teams; HOSPILINK, an hospital information system applications; HOSPILINK DPI, a computerized patient file; HOSPILINK LOOKUP Big Data; eNephro solutions; NOVIAcare solutions; KAP&LINK2, a contact chip card reader terminal and NFC reader; eS-KAP-Ad, a connected nomadic tool incorporating software; KAP-INSIDE, a mobile terminal; and TI-KAP allowing access to contact and contactless cards. Further, the company provides AUTHENTICATOR, a patented authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; ExpressVitale; MédiStory, that automates the transfer of invoicing to the healthcare professional's accounting. Additionally, it offers medical telesecretarial services for healthcare professionals, as well as equipment lease financing solutions. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
Employees
1271
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As European markets face heightened volatility due to unexpected U.S. trade tariffs, the pan-European STOXX Europe 600 Index has experienced its steepest decline in five years. In such uncertain times...
April 8, 2025
Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment eff...
March 28, 2025
In the face of recent market volatility driven by tariff uncertainties and mixed economic data, investors are increasingly seeking stability through dividend stocks. With their potential to provide co...
February 13, 2025
Villers-lès-Nancy, 6 February 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like) Revenue (€&)202...
February 6, 2025
Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software expert...
December 27, 2024
As global markets experience broad-based gains with U.S. indexes approaching record highs, investors are navigating a landscape marked by strong labor market data and stabilizing economic indicators. ...
November 28, 2024
Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue: €158.2 million Return to growth in Q3 (+0.3%) Revenue (€m) 2023Reported basis 2024Reported basis Change /Rep...
November 7, 2024
Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing investment efforts in H1: Revenue: €108....
September 27, 2024
Villers-lès-Nancy, 2 August 2024 - 6:00 p.m. (CET) PRESS RELEASE H1 2024 revenue: €108 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment p...
August 2, 2024
Villers-lès-Nancy, 5 July 2024 - 6:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024 Number of shares comprisin...
July 5, 2024
Next page